BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Magill SS, O'Leary E, Ray SM, Kainer MA, Evans C, Bamberg WM, Johnston H, Janelle SJ, Oyewumi T, Lynfield R, Rainbow J, Warnke L, Nadle J, Thompson DL, Sharmin S, Pierce R, Zhang AY, Ocampo V, Maloney M, Greissman S, Wilson LE, Dumyati G, Edwards JR, Chea N, Neuhauser MM; Emerging Infections Program Hospital Prevalence Survey Team. Assessment of the Appropriateness of Antimicrobial Use in US Hospitals. JAMA Netw Open 2021;4:e212007. [PMID: 33734417 DOI: 10.1001/jamanetworkopen.2021.2007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Bandy SM, Jackson CB, Black CA, Godinez W, Gawrys GW, Lee GC. Molecular Rapid Diagnostics Improve Time to Effective Therapy and Survival in Patients with Vancomycin-Resistant Enterococcus Bloodstream Infections. Antibiotics 2023;12:210. [DOI: 10.3390/antibiotics12020210] [Reference Citation Analysis]
2 Liu R, Gitman MR, Morris AM, So M. Going local: Evaluating guideline adherence and appropriateness of antibiotic prescribing in patients with febrile neutropenia at an academic teaching hospital. Antimicrob Steward Healthc Epidemiol 2023;3:e3. [PMID: 36714288 DOI: 10.1017/ash.2022.353] [Reference Citation Analysis]
3 Arena CJ, Kenney RM, Kendall RE, Tibbetts RJ, Veve MP. Respiratory culture nudge improves antibiotic prescribing for Moraxella catarrhalis and Haemophilus influenzae lower respiratory tract infections. ASHE 2023;3:e23. [DOI: 10.1017/ash.2023.1] [Reference Citation Analysis]
4 Schaub C, Barnsteiner S, Schönenberg L, Bloch N, Dräger S, Albrich WC, Conen A, Osthoff M. Antibiotic treatment durations for common infectious diseases in Switzerland: comparison between real-life and local and international guideline recommendations. J Glob Antimicrob Resist 2022;32:11-7. [PMID: 36572147 DOI: 10.1016/j.jgar.2022.12.002] [Reference Citation Analysis]
5 Wibisono A, Harb G, Crotty M, Rahmanzadeh K, Alexander J, Hunter L, Dominguez E. Quantifying Gram-Negative Resistance to Empiric Treatment After Repeat ExpoSure To AntimicRobial Therapy (RESTART). Open Forum Infect Dis 2022;9:ofac659. [PMID: 36582770 DOI: 10.1093/ofid/ofac659] [Reference Citation Analysis]
6 Park SY, Kim YC, Lee R, Kim B, Moon SM, Kim HB; Korea Study Group for Antimicrobial Stewardship. Current Status and Prospect of Qualitative Assessment of Antibiotics Prescriptions. Infect Chemother 2022;54:599-609. [PMID: 36596676 DOI: 10.3947/ic.2022.0158] [Reference Citation Analysis]
7 Săndulescu O, Viziteu I, Streinu-cercel A, Miron VD, Preoțescu LL, Chirca N, Albu SE, Craiu M, Streinu-cercel A. Novel Antimicrobials, Drug Delivery Systems and Antivirulence Targets in the Pipeline—From Bench to Bedside. Applied Sciences 2022;12:11615. [DOI: 10.3390/app122211615] [Reference Citation Analysis]
8 Smith JT, Manickam RN, Barreda F, Greene JD, Bhimarao M, Pogue J, Jones M, Myers L, Prescott HC, Liu VX. Quantifying the breadth of antibiotic exposure in sepsis and suspected infection using spectrum scores. Medicine 2022;101:e30245. [DOI: 10.1097/md.0000000000030245] [Reference Citation Analysis]
9 Núñez-núñez M, Perez-galera S, Girón-ortega JA, Sandoval Fernández-del-castillo S, Beltrán-garcía M, De Cueto M, Suárez-barrenechea AI, Palacios-baena ZR, Terol-barrero P, Oltra-hostalet F, Arenzana-seisdedos Á, Rodriguez-baño J, Retamar-gentil P. Predictors of inappropriate antimicrobial prescription: Eight-year point prevalence surveys experience in a third level hospital in Spain. Front Pharmacol 2022;13:1018158. [DOI: 10.3389/fphar.2022.1018158] [Reference Citation Analysis]
10 Wingler MJB, Tamma PD. Defining effective durations of antibiotic therapy for community-acquired pneumonia and urinary tract infections in hospitalized children. Curr Opin Infect Dis 2022;35:442-51. [PMID: 35852789 DOI: 10.1097/QCO.0000000000000857] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 So M, Nakamachi Y, Thursky K. Auditing tools for antimicrobial prescribing in solid organ transplant recipients: The why, the how, and an assessment of current options. Transplant Infectious Dis 2022;24. [DOI: 10.1111/tid.13905] [Reference Citation Analysis]
12 Pelle CM, Berger SC, Short MR, Mccalla AW, Foster DL, Owen MC. Impact of a Medication Reconciliation Pharmacist Program on Appropriateness of Community-Acquired Pneumonia Treatment Durations at Hospital Discharge. Hosp Pharm. [DOI: 10.1177/00185787221120151] [Reference Citation Analysis]
13 Lanckohr C, Bracht H. Antimicrobial stewardship. Curr Opin Crit Care 2022. [PMID: 35942707 DOI: 10.1097/MCC.0000000000000967] [Reference Citation Analysis]
14 Johnson MD, Davis AP, Dyer AP, Jones TM, Spires SS, Ashley ED. Top Myths of Diagnosis and Management of Infectious Diseases in Hospital Medicine. Am J Med 2022;135:828-35. [PMID: 35367180 DOI: 10.1016/j.amjmed.2022.03.019] [Reference Citation Analysis]
15 Yow H, Govindaraju K, Lim AH, Abdul Rahim N. Optimizing Antimicrobial Therapy by Integrating Multi-Omics With Pharmacokinetic/Pharmacodynamic Models and Precision Dosing. Front Pharmacol 2022;13:915355. [DOI: 10.3389/fphar.2022.915355] [Reference Citation Analysis]
16 Werth BJ, Dilworth TJ, Escobar ZK, Gross AE, Suda KJ, Morris AM, Mcgregor JC, Kuper K. Reporting behaviors and perceptions toward the National Healthcare Safety Network antimicrobial use (AU) and antimicrobial resistance (AR) modules. Infect Control Hosp Epidemiol 2022. [DOI: 10.1017/ice.2022.131] [Reference Citation Analysis]
17 Mercuro NJ, Medler CJ, Kenney RM, MacDonald NC, Neuhauser MM, Hicks LA, Srinivasan A, Divine G, Beaulac A, Eriksson E, Kendall R, Martinez M, Weinmann A, Zervos M, Davis SL. Pharmacist-Driven Transitions of Care Practice Model for Prescribing Oral Antimicrobials at Hospital Discharge. JAMA Netw Open 2022;5:e2211331. [PMID: 35536577 DOI: 10.1001/jamanetworkopen.2022.11331] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 So M, Walti L. Challenges of Antimicrobial Resistance and Stewardship in Solid Organ Transplant Patients. Curr Infect Dis Rep. [DOI: 10.1007/s11908-022-00778-1] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Yu KC, Gupta V, Kabler H, Watts JA, Amiche A. A multicenter analysis of inpatient antibiotic use during the 2015–2019 influenza seasons in the United States: Untapped opportunities for antimicrobial stewardship. ASHE 2022;2:e140. [DOI: 10.1017/ash.2022.265] [Reference Citation Analysis]
20 Bassetti S, Tschudin-sutter S, Egli A, Osthoff M. Optimizing antibiotic therapies to reduce the risk of bacterial resistance. European Journal of Internal Medicine 2022. [DOI: 10.1016/j.ejim.2022.01.029] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
21 Pfaller MA, Li L, Liu Q, Zhang J, Huband MD, Lindley JM, Mendes RE. In vitro activity of a novel aminomethylcycline antibacterial (KBP-7072), a third-generation tetracycline, against clinical isolates with molecularly characterized tetracycline resistance mechanisms. JAC Antimicrob Resist 2021;3:dlab177. [PMID: 34917942 DOI: 10.1093/jacamr/dlab177] [Reference Citation Analysis]
22 Seymann GB, Bevins N, Wu C, Fitzgerald R. Prevalence of Discordant Procalcitonin Use at an Academic Medical Center. Am J Clin Pathol 2022;157:890-8. [PMID: 34894127 DOI: 10.1093/ajcp/aqab201] [Reference Citation Analysis]
23 Livorsi DJ, Drainoni ML, Reisinger HS, Nanda N, McGregor JC, Barlam TF, Morris AM, Szymczak JE. Leveraging implementation science to advance antibiotic stewardship practice and research. Infect Control Hosp Epidemiol 2021;:1-8. [PMID: 34852212 DOI: 10.1017/ice.2021.480] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
25 Kooda K, Bellolio F, Dierkhising R, Tande AJ. Defining Antibiotic Inertia: Application of a Focused Clinical Scenario Survey to Illuminate A New Target for Antimicrobial Stewardship During Transitions of Care. Clin Infect Dis 2021:ciab872. [PMID: 34596206 DOI: 10.1093/cid/ciab872] [Reference Citation Analysis]
26 Vaughn VM, Hersh AL, Spivak ES. Antibiotic Overuse and Stewardship at Hospital Discharge: The Reducing Overuse of Antibiotics at Discharge (ROAD) Home Framework. Clin Infect Dis 2021:ciab842. [PMID: 34554249 DOI: 10.1093/cid/ciab842] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
27 Puzniak L, Bauer KA, Yu KC, Moise P, Finelli L, Ye G, De Anda C, Vankeepuram L, Gupta V. Effect of Inadequate Empiric Antibacterial Therapy on Hospital Outcomes in SARS-CoV-2-Positive and -Negative US Patients With a Positive Bacterial Culture: A Multicenter Evaluation From March to November 2020. Open Forum Infect Dis 2021;8:ofab232. [PMID: 34141818 DOI: 10.1093/ofid/ofab232] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
28 . Errors in the Abstract Results; Results; Tables 1, 4, and 5; the Conflict of Interest Disclosures; and the Supplement. JAMA Netw Open 2021;4:e219526. [PMID: 33861334 DOI: 10.1001/jamanetworkopen.2021.9526] [Reference Citation Analysis]
29 Suzuki H, Shealy SC, Throneberry K, Stenehjem E, Livorsi D. Opportunities and challenges in improving antimicrobial use during the era of telehealth expansion: A narrative review. ASHE 2021;1:e26. [DOI: 10.1017/ash.2021.191] [Reference Citation Analysis]